Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 7/20 | 0.42 |
| ▸ | NOS1 | P29475 | 7/20 | 0.42 |
| ▸ | NOS2 | P35228 | 7/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | INMT | O95050 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13742940 | 1.00 | NOS3 (0.42) | NOS3NOS1NOS2CYP2D6MEN1 | |
| SCHEMBL12020351 | 1.00 | NOS3 (0.42) | NOS3NOS1NOS2CYP2D6MEN1 | |
| SCHEMBL2729692 | 0.97 | — | — | |
| SCHEMBL1357490 | 0.90 | — | — | |
| Iodide SCHEMBL16038836 | 0.85 | NOS3 (0.35) | NOS3NOS1NOS2KDM4E | |
| SCHEMBL14000046 | 0.81 | — | — | |
| SCHEMBL1760704 | 0.78 | — | — | |
| SCHEMBL8015557 | 0.78 | CYP2D6 (0.41) | NOS3NOS1NOS2CYP2D6MEN1 | |
| SCHEMBL11355992 | 0.74 | MEN1 (0.39) | NOS3NOS1NOS2CYP2D6MEN1 | |
| SCHEMBL21317763 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220403234-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220403234-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE CONTAINING THE SAME | RB1, CRY1, RBX1 | NOS3 4119/4885NOS1 3144/4885NOS2 3428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.